Compare GSK plc (GSK) vs VF Corp (VFC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs VF Corp — how do they compare? GSK plc trades at $50.56 (market cap $102.60B), while VF Corp trades at $14.8 (market cap $5.81B). The key difference: GSK plc is far larger — about 17.7× VF Corp's market cap, and GSK plc pays the higher dividend (3.57%). Which is the better fit depends on your goals.
| GSK | VFC | |
|---|---|---|
Market Cap | $102.60B | $5.81B |
Sector | Health | Consumer Cyclical |
52-Week High | $61.18 | $21.55 |
52-Week Low | $38.22 | $12.21 |
Enterprise Value | $123.04B | $10.09B |
Dividend Yield | 3.57% | 2.44% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About VF Corp
VF designs, produces, and distributes branded apparel and accessories. Its largest apparel categories include action sports, outdoor, and workwear. Its portfolio of about a dozen brands includes Vans, The North Face, Timberland, Supreme, and Dickies. VF markets its products in the Americas, Europe, and Asia-Pacific through wholesale sales to retailers, e-commerce, and branded stores owned by the company and partners. The company has grown through multiple acquisitions and traces its roots to 1899.
Read more on VFC →
